文献速递颈动脉与弓上血管

可吸收西罗莫司洗脱聚合物支架在正常猪颈动脉中的血管反应

Vascular Response Toward an Absorbable Sirolimus-eluting Polymeric Scaffold for Vascular Application in a Model of Normal Porcine Carotid Arteries.
PubMed 文献 · Ann Vasc Surg · 2021-10-11

本研究在14只雌性猪的颈动脉中植入可吸收PLLA/P4HB支架(是否负载西罗莫司)并以裸金属支架为对照,4周后组织形态学评估。可吸收支架管腔面积更小、狭窄率更高,西罗莫司涂层可减轻炎症但未达裸金属支架水平;裸金属支架血管损伤评分略高。

要点

  • 西罗莫司涂层降低聚合物支架炎症评分,但未及裸金属支架水平。
  • 裸金属支架血管损伤评分略高于可吸收支架,技术可行性与安全性相似。

核心结论

  • 在该临床前模型中,新型可吸收聚合物支架(含西罗莫司)用于血管介入的技术可行性与安全性与永久金属支架相似。
  • 聚合物支架炎症倾向较高,西罗莫司涂层可轻度降低炎症,但未达裸金属支架水平。
  • 聚合物支架支架丝厚度较小可能对支架丝间组织长入有积极影响,需在未来支架设计中解决。

研究设计与样本

  • 研究在14只雌性猪的颈总动脉中介入植入可吸收PLLA/P4HB支架(负载西罗莫司涂层或未负载),并以裸金属支架为对照。
  • 全程给予口服双联抗血小板治疗,4周后取出支架段颈总动脉进行组织形态学评估。

主要发现

  • 4周时残余管腔面积:PLLA/P4HB组6.56 ± 0.41 mm²,SIR-PLLA/P4HB组6.90 ± 0.58 mm²,裸金属支架组15.29 ± 1.86 mm²。
  • 4周时狭窄率:PLLA/P4HB组37.56 ± 4.67%,SIR-PLLA/P4HB组35.60 ± 3.15%,裸金属支架组7.65 ± 2.27%。
  • 炎症评分:PLLA/P4HB组1.20 ± 0.19,SIR-PLLA/P4HB组0.96 ± 0.24,裸金属支架组0.54 ± 0.12。
  • 血管损伤评分:裸金属支架组0.74 ± 0.15,PLLA/P4HB组0.54 ± 0.20,SIR-PLLA/P4HB组0.48 ± 0.15。

临床怎么用

  • 可吸收聚合物支架在猪颈动脉模型中技术可行且安全,但再狭窄率显著高于裸金属支架,需优化设计。
  • 西罗莫司涂层可部分减轻聚合物支架的炎症反应,但未完全消除与裸金属支架的差异。
  • 支架丝厚度较小可能促进组织长入,未来支架设计可考虑此因素。

局限性

  • 研究为临床前动物模型,样本量有限(14只雌性猪),结果外推至人体需谨慎。
  • 仅评估4周时间点,缺乏长期降解与血管反应数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fully absorbable polymeric scaffolds, as a potential alternative to permanent metallic stents, are entering the clinical field. The aim of this study is to assess the in vivo biocompatibility of a novel Sirolimus-eluting (SIR) absorbable scaffold based on poly(L-lactide) (PLLA) and poly(4-hydroxybutyrate) (P4HB) for interventional application. METHODS: Absorbable PLLA/P4HB scaffolds either loaded with SIR coating or unloaded scaffolds were implanted interventionally into common carotid arteries of 14 female. Bare metal stents (BMS) served as control. Peroral dual anti-platelet therapy was administered throughout the study. Stented common carotid arteries segments were explanted after 4 weeks, and assessed histomorphometrically. RESULTS: The absorbable scaffolds showed a decreased residual lumen area and higher stenosis after 4 weeks (PLLA/P4HB: 6.56 ± 0.41 mm² and 37.56 ± 4.67%; SIR-PLLA/P4HB: 6.90 ± 0.58 mm² and 35.60 ± 3.15%) as compared to BMS (15.29 ± 1.86 mm² and 7.65 ± 2.27%). Incorporation of SIR reduced the significantly higher inflammation of unloaded scaffolds however not to a level compared to bare metal stent (PLLA/P4HB: 1.20 ± 0.19; SIR-PLLA/P4HB: 0.96 ± 0.24; BMS: 0.54 ± 0.12). In contrast, the BMS showed a slightly elevated vascular injury score (0.74 ± 0.15), as compared to the PLLA/P4HB (0.54 ± 0.20) and the SIR-PLLA/P4HB (0.48 ± 0.15) groups. CONCLUSION: In this preclinical model, the new absorbable polymeric (SIR-) scaffolds showed similar technical feasability and safety for vascular application as the permanent metal stents. The higher inflammatory propensity of the polymeric scaffolds was slightly reduced by SIR-coating. A smaller strut thickness of the polymeric scaffolds might have been a positive effect on tissue ingrowth between the struts and needs to be addressed in future work on the stent design.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kischkel S, Bünger CM, Grabow N, et al. Vascular Response Toward an Absorbable Sirolimus-eluting Polymeric Scaffold for Vascular Application in a Model of Normal Porcine Carotid Arteries. Ann Vasc Surg. 2021. PMID: 34648854. doi:10.1016/j.avsg.2021.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。